Breast cancer is one of the most common cancers among women that is associated with
high mortality. Conventional treatments including surgery, radiotherapy, and chemotherapy …

The proposal of gene therapy to tackle cancer development has been instrumental for the
development of novel approaches and strategies to fight this disease, but the efficacy of the …

Recent efforts in designing nanomaterials to deliver potential therapeutics to the targeted
site are overwhelming and palpable. Engineering nanomaterials to deliver biological …

Triple negative breast cancer (TNBC) is the most fatal subtype among all other types of
breast cancer and there are no targeted chemotherapy for the treatment of TNBC due to the …

Over the last decade, nanotechnology has widely addressed many nanomaterials in the
biomedical area with an opportunity to achieve better-targeted delivery, effective treatment …

Site-specific Fe 2+ generation is promising for tumor therapy. Up to now, reported materials
or systems for Fe 2+ delivery do not naturally exist in the body, and their biological safety …

The increasing occurrence of infectious diseases caused by antimicrobial resistance
organisms urged the necessity to develop more potent, selective, and safe antimicrobial …

Breast cancer (BC) is one of the most common cancers in women worldwide; however, the
successful treatment of BC, especially triple-negative breast cancer (TNBC), remains a …

Over the past decades, significant progress has been made in utilizing nucleic acids,
including DNA and RNA molecules, for therapeutic purposes. For DNA molecules, although …

Macrophages are components of the innate immune system that control a plethora of
biological processes. Macrophages can be activated towards pro-inflammatory (M1) or anti …